protein in oxidanttreated rat liver (79) , and actin in human neutrophils during oxidative burst (22) . Although these were not the result of highthroughput studies, some of the technologies used were then adapted for twodimensional gels for further studies and are at the basis of current redox proteomic techniques. In particular, the first published paper using the expression "redox proteomics" (37) was substantially based on the application of the technique described by Rokutan et al. (79) for 2dimensional (2D) gels.
Most redox proteomic studies published to date report the identification of cytosolic proteins because the analyzed samples were cell lysates. Studies by the group of Mike Murphy, specifically focusing on mitochondria, has identified several mitochondrial proteins susceptible to thiol oxidation (60) . Protein abundance is also a key factor in the identification of oxidized proteins. For instance, when we tried to identify specific biochemical pathways targeted by protein glutathionylation, we could identify glycolytic enzymes, as shown in Fig. 2 , suggesting that glycolysis is potentially regulated by the redox state of protein thiols. In fact, Fig. 2 also shows that many of the glycolytic enzymes undergoing glutathionylation were known in the literature for their enzymatic activity to be affected in by thiol oxidation. This would predict that a shift in the GSH/oxidized GSH (GSSG) ratio may affect the overall anaerobic energy metabolism. However, the focus on glycolytic enzymes may be due to the fact that they are abundant proteins, which preferentially identified by most proteomics techniques (75) .
Subcellular localization of the thiol redox state
This section will discuss the redox state of protein cysteines in different cellular compartments. It will provide some reason for the high prevalence of cytosolic proteins among those undergoing transient posttranslational modifications (PTM), including glutathionylation, and possibly identify understudied areas worth exploring.
Cytosol. The intracellular environment is considered a highly reducing one, mainly due to the 110 mM concentrations of GSH, at a high GSH/GSSG ratio (up to 100/1). This is an unfavourable condition for the formation of disulfide bonds and, in fact, structural disulfide bonds are normally formed in the endoplasmic reticulum that is a more oxidizing environment (GSH/GSSG, 1/1) (50).
Plasma. On the contrary, the extracellular environment is oxidizing. The main free thiol in serum/plasma is represented by cysteine, but that is only in the range of 10 µM and with a reduced/oxidized (cysteine/cystine) ratio of 1/6 (9) . GSH is also present in plasma but in the range of 1 µM (1,000fold less than in the cell) and at a GSH/GSSG ratio around 1 (9) . Other studies also reported that plasma GSH+GSSG is present at at least 10fold lower concentrations than Cys+cystine but while cysteine is mainly oxidized (Cys/cystine ratio around 1/10), glutathione is more reduced, even extracellularly (GSH/GSSG ratio of 10/2) (57). The same study shows that significant amounts of cysteine and GSH are present in the oxidized form in plasma as mixed disulfides with proteins: 40% of total plasma cysteine is present in cysteinylated proteins and 70% of plasma GSH is oxidized as mixed disulfides to form glutathionylated proteins (57); by comparison, Brigelius et al. (14, 15) reported that, in normal liver, 1% of intracellular GSH is present as glutathionylated proteins.
Hence, even if total plasma glutathione is 1/10 of total plasma cysteine/cystine and is predominantly in a reduced state, the plasma concentration of glutathionylated proteins is slightly higher than that of cysteinylated proteins, raising the interesting question of whether protein glutathionylation occurs before secretion. Fig. 3 summarizes the concentration and redox state of thiols in the cell and in plasma that, although coming from the studies cited above and obtained in different models, can provide an idea of the order of magnitude of the different redox states of cysteines.
Structural disulfides in cytoplasmic versus secretory proteins
Most studies on protein structure point out that cytosolic proteins have no disulfides while extracellular proteins have no or little free cysteines (34, 36, 90) . Butera et al. (17) have calculated that, based on Uniprot annotations for 4,000 proteins, about half of the disulfide bonds are in membrane proteins and the other half in proteins containing a secretion signal sequence, but about 5% disulfide bonds are found in nucleoplasmic or cytoplasmic proteins.
Studies using diagonal electrophoresis in primary cardiac myocytes or a neuronal cell line have shown that cytosolic proteins can form disulfide bonds upon exposure to oxidants such as diamide or hydrogen peroxide (13, 30) . These studies introduce the class of transient disulfides, a concept that Linke and Jakob summarized with the title "Not every disulfide lasts forever" (62) . Disulfides also vary in their surface exposure and while the most surfaceexposed are easily reduced, those buried in the threedimensional structure of the protein require prior denaturation of the protein (16) . Accessibility is also important for a cysteine to be susceptible to glutathionylation, because of the size of GSH (307 kDa). This is even more important when glutathionylation occurs by thioldisulfide exchange with GSSG (612 kDa) (45) , and even more if this reaction is catalyzed by glutaredoxin (63) . It is likely that transient disulfides are also surfaceexposed. These disulfides can be intraprotein or interprotein ones and Brennan et al. noted that many of them imply associations with other proteins (13) .
Protein thiols on the plasma membrane
The plasma membrane is at the interface of the intracellular environment and the extracellular one. We might expect, therefore, that protein thiols on the inner side are prevalently reduced and the ones on the exofacial side prevalently oxidized. We are not aware of studies attempting a quantification of the redox state on protein thiols on the two sides of the membrane.
However, a few papers reporting the existence of cell surface, exofacial, thiols have received some attention. Early studies on lymphocytes showed that their surface thiols increased upon mitogenic stimulation (58) . Studies overexpressing or inhibiting protein disulfide isomerase (PDI) showed that this enzyme is important for keeping exofacial thiols in the reduced state (53) . Thus, an active mechanism could be involved in the presence of free thiols on the exofacial side of the plasma membrane despite the extracellular environment being oxidizing. Redox proteomics has been successfully applied to identify membrane protein whose exofacial thiols are redox sensitive (55, 56) .
The secretome
With the term secretome we refer to proteins that are released in the cell culture supernatant or found in circulation. We are aware that a conservative use of the term "secretion" would restrict its use to proteins that are secreted through the classical pathway and have a signal sequence for targeting to secretion via the Golgi system. However, the term "nonclassical secretion" is often used to define nonclassical mechanisms; hence our use of the term "secretion" instead of "release" in this review.
Oxidized proteins in circulation
To our knowledge, only a few plasma proteins have been studied in terms of their redox state.
Serum albumin is a major plasma protein, probably the most abundant secretory protein, and is present in serum at concentrations of 3050 mg/ml. Human serum albumin has 17 cysteines of which only one (Cys34) is not engaged in a structural disulfide. Due to the low concentrations of free thiols in plasma, albumin may well be the main thiol antioxidant in circulation (76, 94) . This can undergo oxidation to form a mixed disulfide with cysteine (cysteinylation), homocysteine (32) or a sulfinic acid (66) . Increased levels of cysteinylated albumin have been associated with intrauterine growth restriction (3).
Transthyretin is a transport protein (the name originates from "transports thyroxine and retinol"), also involved in amyloidosis (83) . It can be found in circulation in the 0.5 mg/ml range as Scysteinylated, Scysteinglycinylated and glutathionylated (42, 84) .
Highmobility group protein box 1 (HMGB1) is a nuclear protein that can be released and act as a proinflammatory danger signal (97) . HMGB1 has 3 redoxactive cysteines (Cys23, Cys45, Cys106). The different redox state of these cysteines also regulates the proinflammatory activity of HMGB1 (103) . In circulation, it can be found with an intramolecular disulfide between Cys23 and Cys45 or sulfonylated on all three cysteines and its oxidation is affected in acetaminophen poisoning (103) .
Pentraxin 3 (PTX3)
is an inflammatory protein related to Creactive protein that is elevated in a number of infectious, inflammatory and cardiovascular diseases (12) .
Formation of disulfidelinked oligomers of PTX3 has been reported and one study has shown that measuring its oxidation state can provide a superior biomarker for sepsis than measurement of total PTX3 (29) .
Studies specifically addressing the proteomic identification of the redox secretome
Despite redox proteomics has been applied to the thiol proteome looking at different forms of thiol oxidation (Snitrosylation, transient disulfides, mixed disulfides), so far highthroughput proteomics of the thiol secretome has only been applied to protein glutathionylation. However, these are very recent studies and hopefully they will be followed up by investigations on other types of thiol oxidation. In particular, given the high concentration of extracellular cysteine it will be important to identify the proteins released as cysteinylated.
We have specifically asked if proteins can be released as glutathionylated by inflammatory macrophages. To answer the question, we have used a strategy employing biotinoylated GSH ethyl ester (BioGEE), originally used to identify glutathionylated proteins in HeLa cells (88) . The principle is based on labelling the intracellular GSH pool with biotinylated GSH. However, because GSH is poorly cell permeable, its ethyl ester is used (98) . This reagent is now commercially available and has been used in over 150 papers on protein glutathionylation.
The experimental design is based on previous publications from other groups. Once a list of proteins is generated by the mass spectrometry (MS) analysis, one has to bear in mind that this proteomics strategy is not quantitative but is highly sensitive and has a number of bias; for instance, the proteins identified could still be bound nonspecifically to the beads, or be a result of the nonspecific leakage from a small number of dead cells. Having identified a protein in a LPSstimulated supernatant does not imply that its secretion is induced by LPS, also because there will always be a small amount of secretion by resting cells, or, again, due to a small amount of dead cells. Therefore, it is imperative that each protein is validated. In our studies, we normally provide the list of the identified proteins as supplementary data but report only those validated in the main body of the manuscript (23) . This makes it possible for others to eventually validate other proteins of interest.
In fact, in order to claim that a protein in the list of those identified by MS is released as glutathionylated and its release is induced by LPS, both arms of the claim need to be confirmed. Typically, a Western blot is required to measure the protein in the supernatant of LPSstimulated versus unstimulated cells. This should be done with a proper number of replicates and, possibly, followed by densitometry and statistical analysis (23) . Of course, if an enzymelinked immunosorbent assay (ELISA) or any other assay (such as an enzymatic assay in case the protein is an enzyme) are available, that would be preferable as it may be more quantitative than a Western blot. Demonstrating that a protein is secreted as glutathionylated is more difficult as it requires immunoprecipitation with an antibody against the specific protein followed by nonreducing gel electrophoresis and Western blot with an antiGSH antibody.
Although we have used this approach, we feel it is not always satisfactory due to the presence of nonspecific bands and the nonoptimal migration in nonreducing conditions that does not allow an exact estimate of the molecular weight of the various bands. A control where the sample is run under reducing conditions, to remove GSH from the protein, will help. Finally, checking on a database, such as Uniprot, that the "glutathionylated" proteins identified actually have a free cysteine available for glutathionylation will avoid embarrassing mistakes.
In some cases, of course, the glutathionylated protein may have already been detected by the MS analysis of the proteins or their peptides at the stage of the identification. Identification of a glutathionylated peptide will also provide the additional information of which cysteine is glutathionylated. However, many protocols for MS analysis include a reducing step, making thus impossible to identify glutathionylated peptides. Table 1 lists proteins secreted as glutathionylated by LPSstimulated macrophages identified as described above. Below we discuss some of them.
Proteins in the redox secretome

Glutathionylated proteins
Redoxins Three proteins in the list are involved in redox regulation and were the first ones we validated. In fact, we had previously identified by redox proteomics intracellular peroxiredoxin (PRDX) 1 (37) and thioredoxin (TRX) 1 (18) among the proteins undergoing glutathionylation in human lymphocytes.
Thioredoxin is a protein thiol/disulfide oxidoreductase catalysing a thioldisulfide exchange reaction. Although its most important function is to keep ribonucleotide reductase in the reduced state, and thus is essential for DNA synthesis (49) , it has a broad substrate specificity and can reduce hundreds of proteins (73) with the overall reaction (1) below:
The oxidized TRX is then reduced back by the NADPHdependent selenoprotein enzyme TRX reductase.
Under oxidative conditions, such as in the absence of TRX reductase to regenerate TRX in its reduced state, TRX can act as an oxidant (39) with the reverse of the reaction above. TRX has long been known to be secreted and was originally described by the group of Yodoi as a leukaemia cell product that stimulates lymphocyte proliferation (89, 96) .
Peroxiredoxins are TRX peroxidases and use reduced TRX as the electron donor in eliminating H 2 O 2 . During its catalytic action, PRDX is first oxidized by H 2 O 2 and then reduced by TRX(SH) 2 with the resulting reaction (2) below:
PRDXs have a very high specificity for TRX and, in general, cannot use other proteins as substrates.
It is very interesting that both PRDXs and their substrate are coreleased under inflammatory conditions. We have hypothesized elsewhere that, because the extracellular environment is an oxidizing one, lacking glutathione and NADPH, these two proteins could act in concert to oxidize other proteins (81) .
Secretion of PRDXs has also been reported previously, when these proteins were originally termed natural killer cell enhancing factors (40) .
Profilin and vimentin were also identified among the intracellular glutathionylated proteins in our pioneering redox proteomics study (37) . Profilin has already been reported by a previous study in the human immunodeficiency virus 1 (HIV1) infected, monocytederived macrophage secretome, although that study did not investigate its redox state (54) . Like profilin, vimentin was also identified previously in the macrophage secretome, although its redox state was not investigated (54, 68) .
Other forms of thiol oxidation
In addition to glutathionylation, disulfidelinked homodimerization has also ben reported in secreted proteins. We found that PRDX1 and PRDX2 need to form disulfidelinked homodimers in order to be secreted. Mutation of the cysteine involved in homodimerization, but not of other cysteines, prevents their secretion (70) .
A similar observation was made for fibroblast growth factor 1 (FGF1) where dimerization occurs during its secretion (67) and mutation of those cysteine involved in homodimerization blocks it (51).
In the case of PRDX1 and 2, disulfidelinked dimerization targets them for secretion via the exosomal route, while FGF1 is then secreted as part of a larger multimeric complex (67) .
Secretion of carbonylated proteins
In terms of irreversible oxidative damage, redox proteomics studies on oxidatively damaged proteins by the Butterfield's group have found, increased carbonylation in some circulating protein in Alzheimer Disease, including haptoglobin β chain, serotransferrin and α2Macroglobulin (28) .
The problem of cell lysis contamination in secretome studies
Whenever studying nonclassical secretion of proteins, the problem arises as to whether their presence in the cell culture supernatant is due to secretion or if it is an artefact due to leakage from a small amount of dying cells in the culture. This problem is often addressed with a shortcut, where cell toxicity is measured by Trypan blue exclusion or by assays where cell viability is assessed by a colorimetric or fluorometric metabolic assay such as those employing the oxidation of 3(4,5 dimethylthiazol2yl)2,5diphenyltetrazolium (MTT). The risk that release of the protein may be due to nonspecific leakage from dead cells is then ruled out with statements like "cell viability was over 95%" or "cell death was less than 5%". However, the real question is whether that 5% (or even a 0.5%) of cell death can account for the observation that a protein is present in the secretome.
We have addressed this problem by assessing not only the cell viability, as described above, but also the percentage of cell death that would be required to account for the amount of protein released in the supernatant. For instance, if the cells are cultured in 24well plates in 1 ml of culture medium that is then analysed to measure the secreted proteins, parallel samples should be set up in the same way and the cells then lysed in 1 ml of buffer. Then comparable volumes/dilutions of the cell lysate or the supernatant should be analyzed by Western blot. Using this approach to the study of PRDX1 secretion, for instance, we calculated that at least 40% cell death would be required to account for the observed release of PRDX1 (23) .
An alternative approach is to measure the release of an irrelevant intracellular protein, such as actin. Although we have done so (23), this may not work in all experimental models as in some cases actin may be also secreted (54) . In general, we strongly recommend a combination of all these methods to rule out nonspecific leakage. 
Methods of proteomics analysis
Culture media and sample preparation
Here we discuss some general considerations of cell culture, sample concentration and cleanup that should be done with the minimum number of steps to limit the loss of protein before prefractionation. To avoid contamination of lowabundance proteins secreted by cells, a serumfree culture medium should be used, whenever possible; phenol redfree media is also preferred as phenol red may interfere with MS analysis and is very difficult to eliminate. Conditioned medium should be spin at high speed (20,000 g at 4°C) in order to eliminate cell debris. Concentration of large volumes of medium can be done by freezedrying (10) (100) . Protein precipitation using organic solvents (such acetone) or trichloroacetic acid is another option to achieve both protein concentration and elimination of undesirable molecules (46) Independent of the strategy used, proteins need to be reduced, alkylated, digested by proteases (trypsin, chymotrypsin, LysC), labeled and desalted on C18 before MS analysis.
Quantitative proteomic profiling by mass spectrometry
Due to the complexity and broad dynamic range of proteins in cell secretomes, pre fractionation techniques are necessary to reduce the complexity of conditioned medium and to enhance proteome coverage enabling the identification of more proteins by MS. The two main proteomic approaches, top down and bottom up, are presented in this section. Particular attention will be given to shotgun proteomics with peptide labeling or labelfree, emerging strategies that take advantage of the most recent advances in separation technology, high scan speed and highresolution analyzers. We will also mention targeted proteomic by Multiple/Selected Reaction Monitoring (MRM/SRM).
Top down proteomics
In the offline strategy, proteins are first separated either by gelbased methods, liquid Capillary electrophoresis (CE) can be directly interfaced with mass spectrometers via ESI and used for intact protein characterization taking advantage of an excellent resolution sizesorted capacity and a good sensitivity (105) .Top down approaches using CE allow elucidation of complex posttranslational modifications to generate information on protein isoforms (59) . However, top down proteomics allow limited proteome coverage identification compared with a bottom up approach.
Bottomup shotgun proteomics
Bottom up shotgun is a modern strategy, now widely used in large scale, detailed, relative quantitative protein profiling in complex mixtures. Recent advances in MS led to the development of several methods for relative protein quantification, including isotopic labeling: stable isotope labeling by amino acids in cell culture (SILAC), isobaric tags for absolute and relative quantification (iTRAQ), isobaric tandem mass tags (TMT), isotopecoded affinity tags (ICAT) and 16 The final step is identification of regulated peptides by targeted MS/MS. Labelfree MS strategies have many advantages, including low cost, highthroughput (no limit to the number of samples and conditions that can be compared), time, as sample preparation is easy (based on SDSPAGE stacking gel purification/ingel digestion (99) or infilter digestion using FASP (101)).
Targeted proteomics
As part of a discovery strategy, SRM, also called MRM, is a method of absolute quantification in targeted proteomic analyses and is usually carried out on triplequadrupole mass spectrometers (QQQ). In this method, isotopic absolute quantification (AQUA), peptides are spiked in complex samples and used as internal standards (41, 95) . AQUA peptide is designed to be identical to the prototypic target peptide generated by sample digestion. Both peptides coelute in a known retention time window and are analyzed simultaneously. The concentration of the target peptide is then determined by measuring the signal response for the target peptide relative to that of the AQUA peptide. In the MRM mode, a particular pair of parent ion and several fragments are selected and detected to ensure the specific detection of lowabundance proteins in highly complex mixtures. The SRM method is specific, highly sensitive and is a useful tool for highthroughput screening of biomarkers in a very large number of clinical samples.
Redox arrays
We soon realized, in the course of our studies on redox proteomics of glutathionylated proteins, that some proteins are found over and over in proteomics studies. In fact, this is a very wellknown bias of the proteomics approach. While MS is very sensitive, in a mixture of proteins the abundant ones are identified more easily and can mask the less abundant ones (75, 78) . For instance, PRDXs account for up to 1% of total cellular proteins (102) . It is very likely that we would miss most of the cytokines or components that are present in the secretome at concentrations in the range of picogram/ml.
We have tried to circumvent this problem setting up a technology that we called "redox arrays" and that are based on commerciallyavailable antibody arrays (71).
These are membranes or glass slides coated with antibodies to up to 1,000 different proteins and are used to identify, in a semiquantitative manner, proteins that are differently expressed in different samples. We have adapted this approach to identify proteins undergoing glutathionylation in the inflammatory secretome. This strategy is outlined in Fig. 6 . The first part is based on the use of BioGEE to attach a biotin tag to glutathionylated proteins described above (section 2.3). Then the supernatant, containing biotinylated (glutathionylated) and nonbiotinylated (non glutathionylated)
proteins, is applied to a membrane array (we used an antibody arrays consisting of 1,000 antibodies immobilized on nitrocellulose membrane by Raybiotech, Norcross, USA), the membranes are washed as per the manufacturer's instruction but taking care of avoiding the use of any reducing agent (included in most protocols) that would remove the biotin tag. Detection with streptavidinperoxidase followed by enhanced chemiluminescence (ECL) will reveal a dark spot if a protein is released as glutathionylated. DTTtreated samples will allow identifying false positive spots. If a protein is released but not glutathionylated, it will not show up.
Using this approach, both for the secretome and for the cell lysate, we could identify 80 potential glutathionylated proteins, most previously unrecognized to be glutathionylated. We use the word "potential" because the same caution should be used as in the MS identification and require validation as described above (section 2.2). In our methodological study we validated two such proteins, soluble IL1 receptor type II (IL1sRII) in the secretome and the tyrosineprotein kinase Lyn is the intracellular fraction (71).
We have tried to establish if this method would allow the identification of low abundance proteins and compared the proteins identified with this study (71) with our previous study using redox proteomics based on 2D gels (37) , that of the study mentioned in section 2.3.1 based on the labelling with BioGEE followed by affinity purification on streptavidin and shotgun proteomics (23) , as well as with a curated database, dbGSH, of known glutathionylated proteins identified so far (http://csb.cse.yzu.edu.tw/dbGSH/) (24) . We then used a published list of over 7,000
human proteins ranked by their abundance in a human osteosarcoma cell line (4) (Fig.7C) . It is improved further in the curated database that clearly includes mainly proteins from proteomic studies but also proteins from studies aimed at specific proteins, and not involving their identification by proteomics (Fig.7D) . The frequency distribution obtained with the redox array method (taken from (71) is surprisingly close to the expected distribution for an unbiased method (Fig.7E) . Needless to say, this approach is far from being unbiased as the proteins for which the antibodies are spotted on the arrays are selected based on some criteria. For instance, if we were to use an antibody array for cytokines and growth factors, the frequency distribution would be skewed in favour of lowabundance proteins because most cytokines are not expressed constitutively and, even when induced, are in the picogram range.
We think that the strategy based on redox arrays can be tailored to identify other forms of oxidation or transient disulfides. For instance, it could be coupled to biotin switch approaches using reductants specific for Snitrosylated proteins (52) . We believe this technique might represent, for the field of redox biology, an equivalent to the arrays used to study the kinome and the phosphoproteome.
Biological significance
Biomarkers of the redox state
The most obvious relevance of the redox secretome is in biomarker discovery. In fact, secreted proteins are likely to be detectable in circulation -an almost essential feature for a successful biomarker. Because reactive oxygen species are shortlived, it is impossible to measure any of them in biological fluids and we have to rely on biomarkers as proxy indicators. Oxidized proteins (such as carbonylated proteins or glutathionylated proteins) can be an indicator of the redox state of the organism provided they are prepared properly. In particular, for thioloxidized proteins it is essential to treat the sample with NEM or another alkylating agent before storage, in order to prevent thioldisulfide exchange reaction with protein thiols or small molecular weight thiols.
Although not a secreted protein, many studies have measured glutathionylated haemoglobin in many disease conditions and found an association with some of them (reviewed in (45)). The same approach could be used for secreted proteins.
Oxidized proteins could be of the same use as glycated haemoglobin in diabetes, that does not just reflect to the level of glucose at a given time point but really is an indicator of the exposure of the organism to high glucose (21) . As mentioned earlier, the example of PTX3 suggests that the redox state of a biomarker may represent an additional dimension, improving its diagnostic or prognostic significance (29) .
Functional significance
We think the study of the redox secretome can lead to the identification of novel soluble mediators (cytokines). Probably the best example of this is thioredoxin which was discovered by Arne Holmgren in Stockholm as a reducing cofactor essential for the catalytic action of ribonucleotide reductase and by Junyi Yodoi in Kyoto as an adult Tcell leukaemia derived factor; Yodoi was expecting to have identified an interleukin1 gamma but once the protein was sequenced it was identified as TRX (104) . Also PRDXs were first identified as natural killer (NK) cell activators even before their enzyme activity was established (85) . The main cytokinelike activities of redoxins are summarized in Table 2 .
The identification of inflammatory cytokines has been a great success story: tumor necrosis factor (TNF) was discovered as an inflammatory mediator in 1985 (7) and by 1998 antiTNF antibodies were approved for use in inflammatory disease. Other cytokines inhibitors followed to block interleukins (IL) IL6, IL1 and IL17.
It may be worth noting that most known cytokines have been discovered either by in silico mining or by biochemical purification of proteins with a biological activity. So far, we think that the only "cytokine" discovered by proteomics is HMGB1, which was observed as it was identified in Coomassie blue stained gels as differentially expressed in the supernatant of macrophages stimulated with LPS compared to unstimulated ones (97) . Thus, the study of the redox secretome may lead to the identification of previously unrecognized mediators and potential pharmacological targets.
As mentioned above, PRDX1, PRDX2 and FGF1 are secreted via disulfidelinked homodimerization. It will be interesting to investigate whether other proteins are secreted via formation of a disulfidelinked dimer as this may eventually describe a family of proteins whose secretion is dependent on the redox state of the cell and/or the extracellular environment. 
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